CAR-T cell therapies: patient access and affordability solutions  Future Sci OA. 2025;11(1):2483613
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40156283

Decision-Analytical Modelling of Medicines in the Middle East: A Systematic Review of Economic Evaluation Studies  Applied Health Economics and Health Policy. 2025
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40221639

Different attitudes towards estimating indirect costs of disease: The example of cancer  J Public Health Res. 2025;14(2):22799036251326636
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40296884

Early access to medicines with added therapeutic value: Measuring and comparing time to medicines access in England, France, Germany, Italy and Spain  Health Policy. 2025;157:105317
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40300221

Examining Consistency Across NICE Single Technology Appraisals: A Review of Appraisals for Paroxysmal Nocturnal Haemoglobinuria  Pharmacoeconomics. 2025;43(5):499-508
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=39934600

Importance of Health Economics and Outcomes Research in the Product Lifecycle  Pharmaceutical Medicine. 2025
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40227495

Is this test fit-for-purpose? Principles and a checklist for evaluating the clinical performance of a test in the new era of in vitro diagnostic (IVD) regulation  Critical Reviews in Clinical Laboratory Sciences. 2025;62(3):182-197
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=39912349

Learning strategies for laypeople to participate in health technology assessment: a scoping review  International Journal of Technology Assessment in Health Care. 2025;41(1):e26
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40223508

Mapping methods gaps between EU joint clinical assessments and local health technology assessment decision-making: an environmental scan of guidance in select EU markets and harmonization challenges Journal of Comparative Effectiveness Research. 2025;14(5):e240240
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40008768

Matching-Adjusted Indirect Comparison Studies in Oncology: A Scoping Review Focused on Reporting Quality  Value Health Reg Issues. 2025;47:101088
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=39999561

The need to consider market access for pharmaceutical investment decisions: a primer  Journal of Comparative Effectiveness Research. 2025;14(5):e250036
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40183520

Regional Citrate Anticoagulation Versus Systemic Heparin in Continuous Kidney Replacement Therapy: Examining the Role of Evidence in Health Technology Assessment  Advances in Therapy. 2025
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40238058

The role and value of real-world evidence in health technology decision-making in France, Germany, Italy, Spain, and the UK: insights on external control arms  International Journal of Technology Assessment in Health Care. 2025;41(1):e25
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40260460

Strengthening health technology assessment for cancer treatments in Europe by integrating causal inference and target trial emulation  Lancet Reg Health Eur. 2025;52:101294
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40255411

A Systematic Review of Economic Evaluations in Clinical Nursing Practices  Journal of Nursing Management. 2024;2024:9939254
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40224743

Using Real-World Evidence for Clinical Development to Address the Gap Between Marketing Authorisation and Reimbursement in European Countries: Insights From Literature Review  Journal of Evaluation in Clinical Practice. 2025;31(3):e70090
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40189820

Utility Studies in Rare Diseases: A Systematic Literature Review  Value in Health. 2025
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40220862